Cardiology faces a 15% projected workforce shortfall by 2038 -- with HRSA projecting only 85% adequacy -- while invasive cardiologists generate $3.48 million in annual revenue and median compensation reaches $630,026 for interventional subspecialists (Source: HRSA, 2025; AMN Healthcare, 2023; MGMA, 2024). Over 70% of cardiologists are approaching retirement age, and the cardiovascular disease fellowship maintains a 100% position fill rate, meaning the supply pipeline is at absolute capacity (Source: AAMC, 2024; NRMP, 2025). Talyx's physician intelligence graph tracks 66,887 physicians across all 50 U.S. states and 61,944 healthcare facilities, providing the systematic intelligence infrastructure PE cardiology platforms require to secure physician talent ahead of the market.
Cardiology faces among the most challenging workforce projections of any medical specialty. HRSA projects cardiovascular disease workforce adequacy at only 83% by 2035, with a slight improvement to 85% in the updated 2038 model -- still a 15% shortfall that translates to thousands of unfilled cardiologist positions nationally (Source: HRSA, 2022; HRSA, 2025).
The AAMC projects medical specialty shortages of 3,800 to 13,400 physicians by 2036, with cardiology contributing significantly to this deficit (Source: AAMC, 2024). The total projected physician shortage across all specialties ranges from 13,500 to 86,000 by 2036 (Source: AAMC, 2024).
| Metric | Value | Source |
|---|---|---|
| MGMA Median -- Noninvasive Cardiology | $559,107 | MGMA 2024 Report |
| MGMA Median -- Invasive Cardiology | $630,026 | MGMA 2024 Report |
| MGMA Median -- Electrophysiology (Eastern) | $676,427 | Yale MGMA Benchmarks, 2025 |
| Doximity Average | $587,360 | Doximity 2025 Report |
| Noninvasive YoY Growth | +3.01% | NEJM CareerCenter, 2024 |
| Invasive YoY Growth | +4.62% | NEJM CareerCenter, 2024 |
| Median Annual wRVUs | 9,200-9,850 | Marit Health, 2025 |
The compensation spread between noninvasive ($559,107) and invasive cardiology ($630,026) -- a gap of over $70,000 -- creates distinct recruitment dynamics for each subspecialty. Electrophysiology commands the highest compensation within the cardiology family, reflecting the procedural intensity and limited fellowship pipeline (Source: MGMA, 2024).
Cardiovascular disease is specifically identified by the AAMC as among the specialties with the highest percentage of physicians over age 55 -- exceeding 70% (Source: AAMC, 2024). This retirement risk is compounded by the fact that the cardiovascular disease fellowship maintains a 100% position fill rate (1,347 of 1,347 positions filled), indicating the training pipeline is at absolute capacity with no room for expansion without new fellowship positions (Source: NRMP, 2025).
The applicant match rate for cardiovascular disease fellowship is 66.3%, meaning approximately one-third of qualified applicants do not match -- the pipeline is bottlenecked at the fellowship level, not at the applicant interest level (Source: NRMP, 2025). Interventional cardiology fills only 76.9% of positions, with 71 unfilled slots across 49 programs in 2025, suggesting emerging subspecialty opportunities (Source: NRMP, 2025).
Invasive cardiologists generate approximately $3,484,375 in annual revenue, and cardiovascular surgeons generate approximately $3,697,916 -- both ranking among the top five revenue-generating specialties in medicine (Source: AMN Healthcare, 2023). Cardiology practices with owned catheterization laboratories, diagnostic imaging, and nuclear cardiology services produce substantial ancillary revenue that amplifies the per-physician economic impact.
The revenue loss from an unfilled noninvasive cardiology position is estimated at approximately $1,150,000 over a six-month vacancy period (Source: Jackson Physician Search, 2024). At the industry-standard daily revenue loss of $7,000 to $9,000 per vacancy day (Source: CompHealth, 2024), cardiology vacancies accumulate losses rapidly.
Cardiology platforms command the fiercest buyer competition of any specialty in the current PE market, with platform-level practices trading at mid-teens EBITDA multiples (13-16x) (Source: FOCUS Investment Banking, 2025). Talyx monitors 742 PE firms active in healthcare, tracking portfolio composition and exit timing patterns that inform cardiology platform competitive positioning. The combination of diagnostic testing revenue, cath lab economics, and recurring patient volumes makes cardiology among the most attractive PE investment verticals.
PE healthcare deal value reached $115 billion globally in 2024 (Source: Bain & Company, 2025), with cardiology capturing a disproportionate share of investor interest. Synergy gains from shared back-office operations typically deliver 200-300 basis points of margin improvement within the first two years of platform integration (Source: FOCUS Investment Banking, 2025).
NPI Registry and CMS Billing Data: Taxonomy code filtering for cardiovascular disease (207RC0000X), interventional cardiology (207RI0011X), and cardiac electrophysiology (207RE0101X). CMS Part B utilization data reveals procedure volumes by CPT code -- catheterizations, echocardiograms, stress tests, EP studies, and device implantations.
Cardiac Catheterization Laboratory Data: State health department facility records, CMS certification databases, and certificate-of-need filings identify cath lab ownership and procedural volume by facility -- critical for platforms where cath lab integration drives economics.
Fellowship Pipeline Intelligence: Talyx's fellowship pipeline intelligence tracks 103 candidates graduating between 2025-2027 (45 in 2025, 49 in 2026, 9 in 2027) across tracked specialties. NRMP Specialties Matching Service data for cardiovascular disease (100% fill rate) and interventional cardiology (76.9% fill rate) combined with ACGME program data, academic publication records, and institutional announcements.
CMS Open Payments (Sunshine Act): Industry payment data reveals device relationships, speaking engagements, consulting arrangements, and research funding -- indicators of professional influence, subspecialty expertise, and potential recruitment leverage.
ACC/AHA Activity Monitoring: American College of Cardiology and American Heart Association membership, committee positions, guideline authorship, and conference participation reveal professional network positioning and thought leadership standing.
Clinical Registry Participation: Participation in ACC's NCDR (National Cardiovascular Data Registry), STS databases, and quality improvement registries indicates data-driven practice patterns and institutional quality commitment.
70%+ of Cardiologists Approaching Retirement Age: Cardiovascular disease ranks among specialties with the highest percentage of physicians over 55 (Source: AAMC, 2024). Combined with the aging patient population -- the 75+ cohort growing 54.7% by 2036 -- demand will surge precisely as supply contracts through retirements (Source: AAMC, 2024).
Fellowship Pipeline at Maximum Capacity: The 100% position fill rate for cardiovascular disease fellowship means every available training slot is occupied. Without new fellowship positions -- constrained by GME funding that was frozen for 25 years until a modest 1,000-position expansion in 2020 -- supply growth is structurally limited (Source: NRMP, 2025; AAMC, 2024).
Subspecialty Recruitment Complexity: Noninvasive cardiology, interventional cardiology, electrophysiology, structural heart, advanced heart failure, and cardiac imaging each represent distinct candidate pools with different training pathways, compensation expectations, and practice infrastructure requirements.
Cath Lab and Infrastructure Requirements: Many cardiologists -- particularly interventionalists and electrophysiologists -- require access to catheterization laboratories, EP suites, or hybrid operating rooms. PE platforms without adequate procedural infrastructure face immediate disqualification from candidate consideration, regardless of compensation competitiveness.
Academic vs. Private Practice Competition: A significant share of cardiologists maintain academic affiliations for research access, fellow supervision, and institutional prestige. PE platforms must articulate value propositions that compete with non-monetary academic benefits while offering superior compensation and equity participation.
| Metric | Description | Intelligence Value |
|---|---|---|
| Procedures Per Year | Annual catheterization, EP study, device implantation, and imaging volumes | Revenue capacity and procedural proficiency validation |
| Referral Source Concentration | Percentage of patient volume from top referring PCPs and specialists | Revenue stability and growth trajectory assessment |
| Hospital Privileging Status | Active privileges at hospitals and ASCs; multi-site practice indicators | Geographic reach and competitive positioning analysis |
| Research Activity Level | Clinical trial participation, publication record, ACC/AHA presentations | Academic orientation and potential retention requirements |
| Managed Care Panel Participation | Insurance network enrollment status across commercial payers | Revenue quality and patient access assessment |
| Retirement Timeline Indicators | Age, career stage, partnership status, succession planning signals | Pipeline planning and replacement timing |
| Device and Industry Relationships | CMS Open Payments data -- consulting fees, research grants, royalties | Professional influence and potential recruitment leverage |
| Subspecialty Certification Status | Board certification in CV disease, interventional, EP, or advanced HF | Candidate credentialing and practice scope assessment |
Cardiologist Candidate Dossiers: Talyx's physician intelligence infrastructure provides cardiology-specific recruitment and retention analytics. Multi-source profiles integrate CMS utilization data, procedural volumes, referral network maps, industry payment records, publication history, and behavioral mobility indicators for targeted recruitment candidates.
Fellowship Pipeline Reports: Semiannual analysis of cardiovascular disease and interventional cardiology fellowship graduates, including program rankings, geographic distribution, subspecialty interests, and early career signals.
Cath Lab and Facility Intelligence: Market-level analysis of catheterization laboratory capacity, ownership structures, procedural volumes, and competitive positioning -- informing both recruitment and facility investment decisions.
Cardiology Market Demand Analysis: MSA-level intelligence combining HRSA workforce projections, population cardiovascular disease burden data, existing provider density, and competitive landscape to identify optimal recruitment and expansion geographies. According to Talyx intelligence data, California (6,609 physicians), Florida (1,945), Texas (1,758), New York (1,331), and Pennsylvania (938) represent the five largest physician markets in Talyx's intelligence graph -- geographic concentrations that directly shape cardiology platform expansion strategy.
Retention Risk Monitoring: Continuous surveillance of employed cardiologists for turnover indicators -- new state license applications, professional profile updates, reduced procedural volumes, and compensation gap analysis against current market benchmarks.
Acquisition Target Intelligence: Practice-level scoring of cardiology groups under consideration for add-on acquisition, incorporating physician age distribution, revenue concentration risk, cath lab ownership, payer mix, and referral network resilience. PE platforms using Talyx's intelligence infrastructure gain cardiology market visibility including compensation benchmarks, competitive positioning, and recruitment pipeline data. Talyx's capability transfer model ensures cardiology intelligence becomes a permanent organizational capability owned by the client.
Cardiologist compensation varies significantly by subspecialty, with MGMA reporting $559,107 for noninvasive cardiology, $630,026 for invasive cardiology, and $676,427 for electrophysiology in the Eastern region (Source: MGMA, 2024; Yale MGMA Benchmarks, 2025). The $70,000+ gap between noninvasive and invasive subspecialties creates distinct recruitment dynamics for each candidate pool. Talyx tracks compensation alongside wRVU production (9,200-9,850 annual units) to help PE platforms structure competitive, subspecialty-appropriate offers.
Cardiovascular disease fellowship maintains a 100% position fill rate -- all 1,347 positions filled in 2025 with zero vacancies -- while the applicant match rate of 66.3% reveals that one-third of qualified candidates fail to match, confirming the constraint is training capacity, not applicant interest (Source: NRMP, 2025). Interventional cardiology fills only 76.9% of positions, with 71 unfilled slots across 49 programs. Congress froze GME positions for 25 years before a modest expansion in 2020, meaning supply growth remains structurally constrained.
Talyx's intelligence infrastructure operates upstream of traditional recruitment by monitoring NPI data, CMS billing patterns, fellowship graduation timelines, and professional profile changes to identify candidates during their decision-making window -- before competitors become aware of their availability. Retained search firm fees of 25-35% of first-year compensation translate to $140,000-$220,000 per cardiologist hire (Source: Hunter Recruiting, 2024). Talyx's approach builds proprietary pipeline intelligence that compounds over time, reducing per-hire costs and compressing time-to-fill.
Schedule a strategic briefing to discuss how Talyx can build intelligence infrastructure for your organization.
Schedule a Briefing